Protein Binding of Antimicrobials: Methods for Quantification and for Investigation of its Impact on Bacterial Killing

被引:50
作者
Beer, Juergen [1 ]
Wagner, Claudia Christina [1 ]
Zeitlinger, Markus [1 ]
机构
[1] Med Univ Vienna, Dept Clin Pharmacol, A-1090 Vienna, Austria
来源
AAPS JOURNAL | 2009年 / 11卷 / 01期
关键词
antimicrobials; pharmacodynamics; protein binding; IN-VITRO ACTIVITY; PARTICULARLY TISSUE PENETRATION; SUBCUTANEOUS ADIPOSE-TISSUE; STAPHYLOCOCCUS-AUREUS; SERUM-PROTEIN; EQUILIBRIUM DIALYSIS; STREPTOCOCCUS-PNEUMONIAE; ANTIBACTERIAL ACTIVITY; LIQUID-CHROMATOGRAPHY; CLINICAL RELEVANCE;
D O I
10.1208/s12248-008-9072-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Plasma protein binding of antimicrobial agents is considered to be a key characteristic of antibiotics as it affects both their pharmacokinetics and pharmacodynamics. However, up to the present, no standard methods for measuring protein binding or for quantification of the influence of protein binding on antimicrobial activity exist. This short-coming has previously led to conflicting results on antibacterial activity of highly protein-bound antibiotics. The present review, therefore, set out to summarize (1) methods for quantification of protein binding, (2) microbiological growth media used for determination of the impact of protein binding on antimicrobial activity of antibiotics, and (3) different pharmacodynamic in vitro studies that are used in this context. The advantages and disadvantages of a wide range of different approaches are discussed and compared. The urgent call for international standardization by microbiological societies and laboratories may be considered as a logical consequence of the presented data.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 75 条
[1]   MICS OF CIPROFLOXACIN AND TRIMETHOPRIM FOR ESCHERICHIA-COLI - INFLUENCE OF PH, INOCULUM SIZE AND VARIOUS BODY-FLUIDS [J].
AAGAARD, J ;
GASSER, T ;
RHODES, P ;
MADSEN, PO .
INFECTION, 1991, 19 :S167-S169
[2]   VANCOMYCIN SERUM-PROTEIN BINDING DETERMINATION BY ULTRAFILTRATION [J].
ACKERMAN, BH ;
TAYLOR, EH ;
OLSEN, KM ;
ABDELMALAK, W ;
PAPPAS, AA .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (04) :300-303
[3]   Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones [J].
Balcabao, IP ;
Alou, L ;
Aguilar, L ;
Gomez-Lus, ML ;
Giménez, MJ ;
Prieto, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (06) :907-909
[4]   Selection of Klebsiella pneumoniae mutants with high-level cefotaxime resistance during growth in serum containing therapeutic concentrations of cefotaxime [J].
Bedenic, B .
CHEMOTHERAPY, 2002, 48 (01) :10-14
[5]   Changes in plasma protein binding have little clinical relevance [J].
Benet, LZ ;
Hoener, BA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) :115-121
[6]  
BERGAN T, 1987, REV INFECT DIS, V9, P713
[7]   Clinical role of protein binding of quinolones [J].
Bergogne-Bérézin, E .
CLINICAL PHARMACOKINETICS, 2002, 41 (10) :741-750
[8]   Effect of protein binding on the in vitro activity and pharmacodynamics of faropenem [J].
Boswell, FJ ;
Ashby, JP ;
Andrews, JM ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (04) :525-532
[9]   Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis [J].
Burkhardt, Olaf ;
Brunner, Martin ;
Schmidt, Stephan ;
Grant, Maria ;
Tang, Yufei ;
Derendorf, Hartmut .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (03) :632-636
[10]   In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives [J].
Cafini, F. ;
Aguilar, L. ;
Gonzalez, N. ;
Gimenez, M. J. ;
Torrico, M. ;
Alou, L. ;
Sevillano, D. ;
Vallejo, R. ;
Prieto, J. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) :1185-1189